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Oxidative stress is a key factor driving the aging
of cells and afteries. Studies suggest that white blood cell
(WBC) telomere length is an index of systemic aging. We,
therefore, investigated the association between WBC
telomere length and oxidized-LDl, and vascular aging,
expressed by the distensibility of the carotid artery. We
studied a random population sample of 216 non-smokers
and 89, smokers. In all subjects, age and gender- adjusted
telomere length was inversely correlated with plasma
oxidized-LDl (regression coefficient : -0.656 kblmgldL;
p:0.0006). Independent of gender, age and mean blood
pressure, carotid distensibility increased with telomere
lengrh (2.33+1.18 l0r/kPa/kb; p:0.05) but decreased with
higher plasma levels of oxidized LDL (-10.7t3.91 10-3lkPa/ mgldL; p:0.006). Adjusted for gender and age,
smokers' telomere length was shorter (6.72 vs 6.91 kb;
p:0.014) and plasma oxidized-LDl level higher (0.52 vs
0.46 mgldL; p:0.03) than in non-smokers. Higher level of
oxidized-LDl-, is associated with shorter WBC telomeres
and increased stiffness of the carotid arlery. Smoking is
marked by increased oxidative stress in concert with
shortened WBC telomere length.
2. INTRODUCTION
The aging ofthe vasculature is a complex process
that in large measure reflects the overall aging of the
individual. Oxidative stress is somehow involved in this
process. (1). We explored the proposiiion that systemic
oxidative stress, expressed in oxidized-LDl, might be a
factor that is common to both systemic and vascular aging.
To this end, we used white blood cell (WBC) telomere
length as an index of systemic aging (2) and the common
carotid artery distensibility as a measure ofvascular aging.
As aging reflects the input of both genetic and
environmental factors, we examined the effect of cigarette
smoking- an important environmental source of free
radicals (3) that might accelerate aging (4) 
- 
on WBC
telomere length, oxidized-LDL and carotid distensibility'
3. MATERIALS AND METHODS
3.1 The cohort
We studied 305 subjects (55.8% women), who
were randomly recruited from the population of a
geographically defined area within the framework of the
Flemish Study on Environment, Genes and Health
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Outcomes (FLEMENGHO). Each volunteer donated a
fasting blood sample and underwent a physical examination
and carotid artery distensibility measurements. Using a
standardized questionnaire, we collected information about
personal and familial medical history, smoking and
drinking habits, and the use of medications. The study was
performed in accordance with the Helsinki Declaration.
The Ethics Committee of the University of Leuven
approved the protocol.
3.2. White blood cell telomere length measurements
WBC telomere length was measured from the
mean of the terminal restriction fragment length, as
described before (5). Briefly, DNA samples were digested
with Hinfl and Àsal (Roche Diagnostics Corporation,
Indianapolis, US) and resolved on 0.5% agarose gels.
DNA was transferred to a positively charged nylon
membrane and telomeric DNA detected by Southern
hybridisation to a digoxigenin 3'-end labeled 5'-
(CCCTAA)3 after overnight incubation at 65" C. The
labelled DNA was visualised using a digoxigenin
luminescent detection procedure and exposure on X-ray
hyperÍilm (Amersham Biosciences, UK). Telomere length
of each sample was the average of duplicate measurements.
If the duplicate for a sample varied by 57o or more, we
repeated the measurement and took the mean of the two
that were less than 5%o apart. This occurred in less than 50Á
of the samples. To control for possible variation between
batches, we ran internal standards on each gel. The
coefficient of variation averaged 1.7%o. The laboratory
conducting the telomere length measurenents was blinded
to all characteristics of the WBC donors. Results of
telomere measurements, identified only by coded ID
numbers, were electronically transmitted and merged with
the covariate data at the Study Coordinating Centre,
Laboratory of Hypertension, Department of Molecular and
Cardiovascular Research, University of Leuven.
3.3. Oxidized-LDL measurements
Venous blood (5mL) was collected into 100 pL
buffer containing 0.1 mgm/L citrate, I mmol/L EDTA, 20
pmol/L vitamin E, 10 pmol/L butylated hydroxytoluene, 20
pmol/L dipyridamole, and l5 mmol/L theophylline. The
blood sample was spun at 30009 for 15 minutes at room
temperature. Within 25 minutes, the supernatant was
stored at -80'C until assayed. We used a monoclonal
antibody 4E6-based competition ELISA for measuring the
plasma levels of oxidized LDL(6,7). The coefhcient of
variation of oxidized LDL was l2o/o.LDL cholesterol, HDL
cholesterol and triglycerides were measured by automated
enzymatic methods (Boehringer, Mannheim, Germany).
We calculated LDL cholesterol from LDL cholesterol and
triglycerides by means of Friedewald's formula,
3,4, Distensibility of the common carotid artery
Vascular measurements were performed after the
individual had rested in the supine position for l5 minutes.
An experienced researcher (TN) performed the
measurements using a pulsed ultrasound wall tracking
system (Wall Track System, Pie Medical, Maashicht, The
Netherlands), which has been validatedl (8).
Measurements were taken at the common carotid arterv 2
cm proximal of the carotid bulb. We used applanation
tonometry with a pencil-shaped probe (Millar Instruments,
Houston, TX) to calibrate the carotid pulse wave to the
diastolic and mean arterial pressure at the level of the
brachial artery, which weÍe measured with a
semiautomated device (Omron HEM 705CP, Kyoto,
Japan). If tonometry was impossible due to obesity or the
presence of arterial plaque in the common carotid arteÍy,
the vessel wall movement contour was used as a surrogate
for the tonometrically derived pulse pressure conÍour with
calibration as described above (9). The distensibility
coefficient (DC) was derived from the diastolic cross-
sectional area (A), the systolic increase in cross-sectional
area (ÀA) and the local pulse pressure (ÁP) according to
the formula: DC: (^A/Ay^P. A and ÀA were calculated as
A: n x (Dl2)2 and AA= 7t x [(D+^D) l2]2 - n x (Dl2)2.
3.5. Statistical Analysis
We used SAS software version 8.1 (SAS Institute
Inc, Cary, NC) for database management and statistical
analysis. For comparison of means and proportions, we
applied Student's t-test and tl'le chi-statistic, respectively.
We searched for possible covariates of the phenotypes
under study by stepwise regression with the p values for
independent variables to enter and stay in the model set at
0.05. In multiple means tests, we applied Bonferroni's
correction to adjust the significance levels.
4. RBSULTS
4.1. Characteristics ofthe cohort
Mean age of the 142 men and 163 women was
similar and averaged 42.5 (SD: 16.5, range l2-81) years.
Median daily smoking amounted to l5 cigarettes (inter-
quartile range, 10-25) in 45 male smokers and 44 female
smokers. Smokers and non-smokers had similar sex ratio,
age, and carotid distensibility (table 1). Cornpared with
non-smokers, smokers reported more frequently alcohol
intake and displayed higher levels of serum LDL
cholesterol and plasma oxidized-LDl (table l).
4.2. WBC telomere profile
WBC telomere length decreased with age (-0.024
,t0.003 kb per year; p<0.0001). Age-adjusted telomere
length was shorter in men than women (6.77+0.05 kb vs
6.92+0.05 kb; p:0.028). In stepwise regression analysis,
telomere length was independently and negatively
correlated with age and was shorter in males than females
and in smokers than non-smokers. These three covariates
respectively explained 265% (p<0.0001), 1.2% (p:0.036)
and 1.7%o (p:0.011) of the variance in telomere length.
After gender and age adjustments, telomere length was
signif,rcantly shorter in smokers than non-smokers
(6.72+0.06 vs ó.91+0.04 kb; p:0.014) and decreased with
the number ofpack years (f,lgure l).
4.3. Oxidized-LDL
Plasma oxidized LDL increased with age
(regression coefficient tSE, 0.001610.0006 mg/dllyear;
p:0.008). Adjusted for age, men and women had the same
level of oxidized-LDl (0.48+0.02 vs. 0.47+0.02 mgldL;
p:0.11), while smokers had higher levels of oxidized-LDl
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Table l. Characteristics of smokers and non-smokers
Smokers ín=89)
Clinical tèatures
Women, No. (%) I 19 0 (55.1 45.0 (49.5) 0.3'7
C)n oral contracentives No íoln) 20.0 6.8' Il.0 (24.4\ 0.49
Age, years 42.1 '7 .9) 46.1 12.7) 0.51
Bodv mass index- ks/rn' 25.0 6) 744 0.zl
Systolic blood pressure, mrHg 122.9 16.I 125,0 ( 13. I 0.27
Diastolic blood oressure. mmHs /o o 1.7 ) 77 .7 10.4) 0.44
Alcohol use. No. í%) 3.0 (29.2\ 44.0 (48.4 0.0013
Serum total cholesterol- ms/dl 208.0 (4 2t9.0 (45.6 0.06
Serurn LDL cholesterol- ms/dl t2.0 (39 3 't8 0 (40 2 0.07
Serum HDL cholesterol. mc/dl 52.2 (54.6\ 5 (5ó.0) 0.87
Serurn triclvcerides. rnc/dl 23.6 (12s 0\ 225.9 029.3 0.88
PhenotvDes' - '' .. ::
Telomere lensth. kb 6.91 (0.6'7\ 6.75 (0.6',7\ 0.04
Plasrna oxidized-LDL. ms,/dl 0.46 (0.17' 0.52 í0. I 9) 0.02
Carotid distensibilitu l0-'/kPa o l5.8) 27.1 lt.9) 0.7 3
Telomere length and oxidized-LDL
p comparison between smokers and non-smokers, Values are arithmetic (SD) or geometric (95o/o Cl) means or nunbering
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Figure 1. The relations between age-adjusted telomere length, cigarette smoking (pack-years),
distensibility. *Telomere length was age-adjusted.
than non-smokers (0.52+0.01 vs. 0.46+0.02 mg/dl;
p:0.03) and plasma oxidized-LDL increased with the
number of pack years (0.003010.0009 mg/dL/yeaÍ'
p:0.0002).
4.4. Carotid artery distensibility
In stepwise multiple regression, carotid distensibility
was lower in men (-3.7111.41 l0r/kPa; p=0.009) and
decreased with age (-0.412t0.1 I l0-i/kPa/years; p=0.0002)
and mean arterial pressure (-0.46310.18 l0r/kPa/mmHg;
p:0.012). These three covariates explained 15%
(p=0.0094), 32.60/o (p<0.0001) and 2.8% (p=0.0005) of the
variance in carotid distensibility.
4.5, Associations of WBC, telomere length, oxidized-
LDL and carotid distensibility
After adjustment for gender and age, a 0.1 1+0.03
kb shorter telomere length was associated with a l-SD
increase (0. l7 mg/dl-) in plasma oxidized-LDl (p:0.0006)
(Figure 1). Additional adjustment for smoking did not alter
this relation. Adjusted for gender, age and mean blood
pressure, carotid distensibility increased with telomere
length (2.33+1.18 1O-3/kPa/kb; p:0.05), but decreased with
higher plasma levels of oxidized-LDl (-10.713.91 l0-





'/kPa/mg/dL; p-0.006) (figure 2). Neither age-adjusted
telomere length nor carotid distensibility were associated
with lipid parameters other than oxidized- LDL.
5. DISCUSSIO}I
Telomere attrition results from somatic cell
replication and oxidative stress may further accelerates this
process (10). Thus, telomere length represents a record of
the replicative history of cells and in vivo it might also
reflect the cumulative oxidative stress burden over the
lifetime ofthe individual. A body ofresearch supports the
idea that WBC telomere length is an index of biological age
(aging) in that individuals with a host of aging-related
disease, marked by increased oxidative stress and
inflammation, are more likely to have shortened WBC
telomere length (11-17). This is particularly the case for
age-related vascular disease (1 8,19).
Our key finding is that telomere length inversely
correlates with the plasma level of oxidized-LDl, a
biomolecular marker of systemic oxidative stress. In
addition, age-adjusted, telomere length was 190 bp shorter
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Figure 2. Association between carotid distensibilify and
oxidized-LDL
finding in another cohort (20). In telomeric year
equivalence (based on telomere aftrition rate of 0.024
kb/year), smokers were biologically older than non-
smokers by roughly 8 years. This effect of smoking on
telomere length corresponds with Doll's observations on
mortality and smoking showing that smokers on average
die about l0 years earlier than lifelong non-smokers (210)
and it further suppolts the concept that smoking accelerates
systemic aging (4)^
Epidemiological studies demonstrated that
tobacco smoke is a major cause ofboth cancer and vascular
diseases (21). More than 3800 chemicals are present in
tobacco smoke, which may cause oxidative stress via
biotransformation, or by macrophage activation (22,23).
Tobacco smoke also increases LDL oxidation and may
enhance the production of small-dense LDL, which is more
readily oxidize d (24,25).
Arterial stiffness is an index of vascular aging
and an important risk factor that independently predicts
cardiovascular death and death related to other factors (26).
A number of studies have examined the relations between
WBC telomere length and indicators of vascular aging and
cardiovascular risks in humans (14,27,28). Given that
cardiovascular risks increase with age, biologically, the age
of individuals with relatively short telomeres may be more
advanced than their chronological age would indicate.
Support for such a concept has emerged from the hnding
that telomere length, as expressed in WBC, is shorter in
subjects with atherosclerosis than in their age-matched
peers (14,29). The unifying thread for short WBC telomere
length and vascular lesions may well be oxidative stress.
Statins promote potent systemic antioxidant
effects in vivo through suppression of different oxidation
pathways, including the generation of myeloperoxidase-
derived and nitric oxide-derived oxidants (30). Recently, a
beneficial effect of statins on telomere biology has been
described. In all subjects, the sex and age adjusted
telomere length was independently and inversely correlated
with plasma oxidized-LDl. Oxidative stress is central to
the aging process (30,31) and it may accelerate the rate of
telomeric erosion per replicative cycle (10). While,
epidemiologic studies cannot elucidate such mechanistic
connections, as observed in our population-based cohort,
WBC telomere length was inversely associated with plasma
levels of oxidized-LDl- a finding in agreement with
previous observations, which estimated oxidative stress by
urinary isoprostanes (13,17). In our study, oxidative stress
was reflected by oxidized-LDl. lncreased LDL oxidation
is associated with coronary arlery disease. Circulating
oxidized LDL does not originate from extensive metal ion-
induced oxidation in the blood but from mild oxidation in
the arterial wall by cell-associated lipoxygenase and/or
myeloperoxidase (32).
We showed for the first time that in the
population at large telomere length is inversely associated
with plasma levels of oxidized-LDl. Thus oxidative stress
and inflammation, as exemplified by oxidized LDL, likely
play an important role in biological ageing, a process which
may be accelerated in smokers.
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